Brief: Tango Therapeutics Q1 Basic EPS USD -0.32
13/05/2026 21:08
May 13 (Reuters) - Tango Therapeutics Q1 operating expenses USD 48.769 million. Q1 operating income USD -48.769 million Q1 net income USD -45.514 million Q1 EPS USD -0.32
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,